• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人骨形态发生蛋白II型受体胞外域配体结合特性的表征

Characterization of ligand-binding properties of the human BMP type II receptor extracellular domain.

作者信息

Yin Huiran, Yeh Lee-Chuan C, Hinck Andrew P, Lee John C

机构信息

Department of Biochemistry, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA.

出版信息

J Mol Biol. 2008 Apr 18;378(1):191-203. doi: 10.1016/j.jmb.2008.02.031. Epub 2008 Mar 4.

DOI:10.1016/j.jmb.2008.02.031
PMID:18342887
Abstract

ActR-IIA, ActR-IIB, and BMPR-II are low-affinity type II receptors that bind bone morphogenetic proteins (BMPs) in the same overall manner. The binding of BMPs by ActR-IIs has been analyzed structurally and functionally, but no detailed analysis of BMPR-II has been reported. The objective of this study was to determine ligand-binding epitopes and specificity determinants in two regions, the hydrophobic patch and the A-loop of the BMPR-II extracellular domain (ECD). A series of alanine-substituted variants was generated using a recently published X-ray structure of the unliganded form of the ovine BMPR-II ECD as a guide. These variants were characterized using one-dimensional NMR and functional activity assays with BMP-2, BMP-7 and GDF-5 as ligands. The results showed that alanine substitutions of conserved residues W85 and Y113 within the hydrophobic patch of the ECD differentially perturbed BMP ligand binding without disrupting receptor folding, suggesting that they are critical determinants for ligand binding and ligand specificity. Our results further revealed that the nonconserved residue L69 in the hydrophobic patch contributes to ligand-binding activity and specificity. Mutations of several residues within the A-loop resulted in minimal effects on the binding of the different BMP ligands. Overall, these observations identify several amino acid residues that play different roles in BMPR-II and ActR-II and thereby enable BMPR-II and ActR-IIs to bind different subclasses of BMP ligands.

摘要

激活素受体IIA(ActR-IIA)、激活素受体IIB(ActR-IIB)和骨形态发生蛋白受体II(BMPR-II)是低亲和力的II型受体,它们以大致相同的方式结合骨形态发生蛋白(BMP)。激活素受体II(ActR-IIs)与BMP的结合已在结构和功能上进行了分析,但尚未见有关BMPR-II的详细分析报道。本研究的目的是确定BMPR-II细胞外结构域(ECD)的两个区域,即疏水斑块和A环中的配体结合表位和特异性决定因素。以最近发表的绵羊BMPR-II ECD未结合配体形式的X射线结构为指导,生成了一系列丙氨酸取代变体。使用一维核磁共振以及以BMP-2、BMP-7和生长分化因子5(GDF-5)作为配体的功能活性测定对这些变体进行了表征。结果表明,ECD疏水斑块内保守残基W85和Y113的丙氨酸取代对BMP配体结合有不同程度的干扰,但不破坏受体折叠,这表明它们是配体结合和配体特异性的关键决定因素。我们的结果进一步表明,疏水斑块中的非保守残基L69有助于配体结合活性和特异性。A环内几个残基的突变对不同BMP配体的结合影响最小。总体而言,这些观察结果确定了几个在BMPR-II和ActR-II中发挥不同作用的氨基酸残基,从而使BMPR-II和ActR-II能够结合不同亚类的BMP配体。

相似文献

1
Characterization of ligand-binding properties of the human BMP type II receptor extracellular domain.人骨形态发生蛋白II型受体胞外域配体结合特性的表征
J Mol Biol. 2008 Apr 18;378(1):191-203. doi: 10.1016/j.jmb.2008.02.031. Epub 2008 Mar 4.
2
A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.沉默的氢键可通过突变被激活,用于骨形态发生蛋白-2(BMP-2)与激活素IIB型受体的高亲和力相互作用。
BMC Struct Biol. 2007 Feb 12;7:6. doi: 10.1186/1472-6807-7-6.
3
A host-guest relationship in bone morphogenetic protein receptor-II defines specificity in ligand-receptor recognition.配体-受体识别中骨形态发生蛋白受体-II 的主体-客体关系定义了特异性。
Biochemistry. 2012 Sep 4;51(35):6968-80. doi: 10.1021/bi3003023. Epub 2012 Aug 23.
4
The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists.骨形态发生蛋白-2(BMP-2)与骨形态发生蛋白受体-IA(BMPR-IA)复合物的晶体结构及BMP-2拮抗剂的产生。
J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 1):S7-14.
5
High resolution structures of the bone morphogenetic protein type II receptor in two crystal forms: implications for ligand binding.骨形态发生蛋白II型受体两种晶体形式的高分辨率结构:对配体结合的影响
Biochem Biophys Res Commun. 2006 Dec 29;351(4):831-8. doi: 10.1016/j.bbrc.2006.10.109. Epub 2006 Nov 10.
6
BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II.骨形态发生蛋白-2拮抗剂源自受体骨形态发生蛋白受体-II低亲和力结合表位的改变。
EMBO J. 2000 Jul 3;19(13):3314-24. doi: 10.1093/emboj/19.13.3314.
7
Folding and binding integrity of variants of a prototype ligand-binding module from the LDL receptor possessing multiple alanine substitutions.具有多个丙氨酸取代的低密度脂蛋白受体原型配体结合模块变体的折叠和结合完整性。
Biochemistry. 2005 Apr 5;44(13):5075-85. doi: 10.1021/bi047575j.
8
Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome.骨形态发生蛋白-2 I型受体复合物的结构分析揭示了青少年息肉病综合征中受体失活的机制。
J Biol Chem. 2008 Feb 29;283(9):5876-87. doi: 10.1074/jbc.M706029200. Epub 2007 Dec 26.
9
A single residue of GDF-5 defines binding specificity to BMP receptor IB.生长分化因子5的单个残基决定了对骨形态发生蛋白受体IB的结合特异性。
J Mol Biol. 2005 Jun 24;349(5):933-47. doi: 10.1016/j.jmb.2005.04.015. Epub 2005 Apr 22.
10
Inhibition of BMP receptor synthesis by antisense oligonucleotides attenuates OP-1 action in primary cultures of fetal rat calvaria cells.反义寡核苷酸对骨形态发生蛋白受体合成的抑制作用减弱了骨形成蛋白-1在胎鼠颅骨细胞原代培养中的作用。
J Bone Miner Res. 1998 Dec;13(12):1870-9. doi: 10.1359/jbmr.1998.13.12.1870.

引用本文的文献

1
BMP3 inhibits TGFβ2-mediated myofibroblast differentiation during wound healing of the embryonic cornea.骨形态发生蛋白3在胚胎角膜伤口愈合过程中抑制转化生长因子β2介导的肌成纤维细胞分化。
NPJ Regen Med. 2022 Jul 25;7(1):36. doi: 10.1038/s41536-022-00232-9.
2
Crystal structures of BMPRII extracellular domain in binary and ternary receptor complexes with BMP10.BMPRII 胞外结构域与 BMP10 的二元和三元受体复合物的晶体结构。
Nat Commun. 2022 May 3;13(1):2395. doi: 10.1038/s41467-022-30111-2.
3
Association of distinct type 1 bone morphogenetic protein receptors with different molecular pathways and survival outcomes in neuroblastoma.
1型骨形态发生蛋白不同受体与神经母细胞瘤中不同分子途径及生存结果的关联
Neuronal Signal. 2020 Apr 23;4(1):NS20200006. doi: 10.1042/NS20200006. eCollection 2020 Apr.
4
Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson's disease.靶向中脑多巴胺能神经元中的骨形态发生蛋白信号传导作为帕金森病的一种治疗方法。
Neuronal Signal. 2017 Mar 31;1(2):NS20170027. doi: 10.1042/NS20170027. eCollection 2017 Apr.
5
Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signaling.转铁蛋白受体 2 通过 BMP 和 Wnt 信号通路控制骨量和病理性骨形成。
Nat Metab. 2019 Jan;1(1):111-124. doi: 10.1038/s42255-018-0005-8. Epub 2019 Jan 7.
6
TGF-β Superfamily Regulation of Follicle-Stimulating Hormone Synthesis by Gonadotrope Cells: Is There a Role for Bone Morphogenetic Proteins?TGF-β 超家族对促性腺激素细胞合成卵泡刺激素的调节:骨形成蛋白是否有作用?
Endocrinology. 2019 Mar 1;160(3):675-683. doi: 10.1210/en.2018-01038.
7
Structural Biology and Evolution of the TGF-β Family.转化生长因子-β家族的结构生物学与进化
Cold Spring Harb Perspect Biol. 2016 Dec 1;8(12):a022103. doi: 10.1101/cshperspect.a022103.
8
An investigation of BMP-7 mediated alterations to BMP signalling components in human tenocyte-like cells.研究骨形态发生蛋白 7 对人肌腱细胞样细胞中骨形态发生蛋白信号成分的影响。
Sci Rep. 2016 Jul 11;6:29703. doi: 10.1038/srep29703.
9
Production, Isolation, and Structural Analysis of Ligands and Receptors of the TGF-β Superfamily.转化生长因子-β超家族配体与受体的产生、分离及结构分析
Methods Mol Biol. 2016;1344:63-92. doi: 10.1007/978-1-4939-2966-5_4.
10
N-linked glycosylation of the bone morphogenetic protein receptor type 2 (BMPR2) enhances ligand binding.骨形态发生蛋白受体 2(BMPR2)的 N 连接糖基化增强了配体的结合。
Cell Mol Life Sci. 2014 Aug;71(16):3165-72. doi: 10.1007/s00018-013-1541-8. Epub 2013 Dec 15.